Routy et al. found that melanoma patients treated with antibiotics, alongside anti-PD-1/anti-PD-L1 ICI, had a lower survival rate, and metagenomic analyses of patients’ faecal GM showed a compositional difference [58]. The gene discussed is PDCD1; the disease is melanoma.